[1] NAUTH A, SCHEMITSCH E, NORRIS B, et al. Critical-Size Bone Defects: Is There a Consensus for Diagnosis and Treatment? J Orthop Trauma. 2018;32(Suppl 1):S7-S11.
[2] FERNANDEZ DE GRADO G, KELLER L, IDOUX-GILLET Y, et al. Bone substitutes: a review of their characteristics, clinical use, and perspectives for large bone defects management. J Tissue Eng. 2018; 9(4):1-18.
[3] WANG W, YEUNG KWK. Bone grafts and biomaterials substitutes for bone defect repair: A review. Bioact Mater. 2017;2(4):224-247.
[4] CAMPANA V, MILANO G, PAGANO E, et al. Bone substitutes in orthopaedic surgery: from basic science to clinical practice. J Mater Sci Mater Med. 2014;25(10):2445-2461.
[5] 周思佳,姜文学,尤佳.骨缺损修复材料:现状与需求和未来[J].中国组织工程研究,2018,22(14):2251-2258.
[6] CASTILLO-DALÍ G, VELÁZQUEZ-CAYÓN R, SERRERA-FIGALLO MA, et al. Importance of Poly(lactic-co-glycolic acid) in Scaffolds for Guided Bone Regeneration: A Focused Review. J Oral Implantol. 2015;41(4):e152-157.
[7] 孙梦洁,金巨楼,杨军星,等.脱钙骨基质在骨缺损修复中的应用与改性研究概况[J].现代口腔医学杂志,2018,32(4):229-233.
[8] SANTOS DV, CASADEI APM, PEREIRA RV, et al. Development of Polymer/Nanoceramic Composite Material with Potential Application in Biomedical Engineering. Mater Sci Forum. 2012;727:1142-1146.
[9] FÉLIX LANAO RP, JONKER AM, WOLKE JGC, et al. Physicochemical properties and applications of poly(lactic-co-glycolic acid) for use in bone regeneration. Tissue Eng Part B Rev. 2013;19(4):380-390.
[10] ZHAO D, ZHU T, LI J, et al. Poly(lactic-co-glycolic acid)-based composite bone-substitute materials. Bioact Mater. 2021;6(2):346-360.
[11] HUANG J, XIA X, ZOU Q, et al. The long-term behaviors and differences in bone reconstruction of three polymer-based scaffolds with different degradability. J Mater Chem B. 2019;7(48):7690-7703.
[12] GENTILE P, CHIONO V, CARMAGNOLA I, et al. An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering. Int J Mol Sci. 2014;15(3):3640-3659.
[13] 石桂欣,王身国,贝建中.聚乳酸与聚乳酸-羟基乙酸多孔细胞支架的制备及孔隙的表征[J].功能高分子学报,2001,4(1):7-11.
[14] 王珊,花亚冰,高翔,等.注射用乳酸-羟基乙酸共聚物微球的体内外相关性研究进展[J].药学学报,2020,56(1):158-168.
[15] CAI Q. Enzymatic degradation behavior and mechanism of Poly(lactide-co-glycolide) foams by trypsin. Biomaterials. 2003;24(4):629-638.
[16] 蔡晴,贝建中,王身国,等.乙交酯/丙交酯共聚物的体内外降解行为及生物相容性研究[J].功能高分子学报,2000,13(3):249-254.
[17] SOLHEIM E, SUDMANN B, BANG G, et al. Biocompatibility and effect on osteogenesis of poly(ortho ester) compared to poly(DL-lactic acid). J Biomed Mater Res. 2000;49(2):257-263.
[18] DAI Y, SHEN T, MA L, et al. Regeneration of osteochondral defects in vivo by a cell-free cylindrical poly(lactide-co-glycolide) scaffold with a radially oriented microstructure. J Tissue Eng Regen Med. 2018;12(3): e1647-e1661.
[19] EPPLEY BL, MORALES L, WOOD R, et al. Resorbable PLLA-PGA Plate and Screw Fixation in Pediatric Craniofacial Surgery: Clinical Experience in 1883 Patients. Plast Reconstr Surg. 2004;114(4):850-856.
[20] ZHU Y, LI D, ZHANG K, et al. Novel Synthesized Nanofibrous Scaffold Efficiently Delivered hBMP-2 Encoded in Adenoviral Vector to Promote Bone Regeneration. J Biomed Nanotechnol. 2017;13(4):437-446.
[21] 陈娇,舒莉萍,李轩泽,等.聚乳酸-羟基乙酸共聚物负载人骨髓间充质干细胞构建组织工程骨[J].中国组织工程研究,2019,23(26): 4109-4114.
[22] 杨祖坤,贾璐,韩利萍,等.3D打印PLGA支架修复大鼠上颚骨缺损的实验研究[J].南京医科大学学报(自然科学版),2020,40(8): 1125-1129.
[23] BOSE S, ROY M, BANDYOPADHYAY A. Recent advances in bone tissue engineering scaffolds. Trends Biotechnol. 2012;30(10):546-554.
[24] 杨艳芳.动/静态条件下PLGA与PLGA/β-磷酸三钙多孔支架的降解与释药行为[D].天津:天津大学,2010.
[25] DANHIER F, ANSORENA E, SILVA JM, et al. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161(2): 505-522.
[26] TRUONG T, JONES KS. Capsaicin reduces PLGA-induced fibrosis by promoting M2 macrophages and suppressing overall inflammatory Response. J Biomed Mater Res A. 2018;106(9):2424-2432.
[27] LIU WC, CHEN S, ZHENG L, et al. Angiogenesis Assays for the Evaluation of Angiogenic Properties of Orthopaedic Biomaterials - A General Review. Adv Healthc Mater. 2017;6(5):1600434.
[28] XIA P, WANG S, QI Z, et al. BMP-2-releasing gelatin microspheres/PLGA scaffolds for bone repairment of X-ray-radiated rabbit radius defects. Artif Cells Nanomed Biotechnol. 2019;47(1):1662-1673.
[29] WANG T, GUO S, ZHANG H. Synergistic Effects of Controlled-Released BMP-2 and VEGF from nHAC/PLGAs Scaffold on Osteogenesis. Biomed Res Int. 2018;2018:3516463.
[30] DUAN C, LIU J, YUAN Z, et al. Adenovirus-mediated transfer of VEGF into marrow stromal cells combined with PLGA/TCP scaffold increases vascularization and promotes bone repair in vivo. Arch Med Sci. 2014; 10(1):174-181.
[31] DU C, YAO C, LI N, et al. Cell sheet-engineered bones used for the reconstruction of mandibular defects in an animal model. Exp Ther Med. 2015;10(6):2216-2220.
[32] RONG ZJ, YANG LJ, CAI BT, et al. Porous nano-hydroxyapatite/collagen scaffold containing drug-loaded ADM-PLGA microspheres for bone cancer treatment. J Mater Sci Mater Med. 2016;27(5):89.1-89.12.
[33] LI Y, ZHANG ZZ. Sustained curcumin release from PLGA microspheres improves bone formation under diabetic conditions by inhibiting the reactive oxygen species production. Drug Des Devel Ther. 2018;12: 1453-1466.
[34] WANG X, WU X, XING H, et al. Porous Nanohydroxyapatite/Collagen Scaffolds Loading Insulin PLGA Particles for Restoration of Critical Size Bone Defect. ACS Appl Mater Interfaces. 2017;9(13):11380-11391.
[35] WANG YH, RAJALAKSHMANAN E, WANG CK, et al. PLGA-linked alendronate enhances bone repair in diaphysis defect model. J Tissue Eng Regen Med. 2017;11(9):2603-2612.
[36] KWON BJ, SEON GM, LEE MH, et al. Locally delivered ethyl-2,5-dihydroxybenzoate using 3D printed bone implant for promotion of bone regeneration in a osteoporotic animal model. Eur Cell Mater. 2018;35:1-12.
[37] JIA P, CHEN H, KANG H, et al. Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis. J Biomed Mater Res A. 2016;104(10):2515-2527.
[38] GAO J, HUANG G, LIU G, et al. A biodegradable antibiotic-eluting PLGA nanofiber-loaded deproteinized bone for treatment of infected rabbit bone defects. J Biomater Appl. 2016;31(2):241-249.
[39] ARAGÓN J, FEOLI S, IRUSTA S, et al. Composite scaffold obtained by electro-hydrodynamic technique for infection prevention and treatment in bone repair. Int J Pharm. 2019;557:162-169.
[40] LIMIRIO PHJO, ROCHA FS, BATISTA JD, et al. The Effect of Local Delivery Doxycycline and Alendronate on Bone Repair. AAPS PharmSciTech. 2016;17(4):872-877.
[41] 唐文胜,蒋电明.羟基磷灰石及其复合材料在骨修复中的作用及研究进展[J].中华创伤骨科杂志,2003,5(4):96-99.
[42] 王德欣,许战武,裴国献.骨髓间充质干细胞在淫羊藿苷/羟基磷灰石/聚乳酸-羟基乙酸共聚物支架上的成骨[J].中国组织工程研究,2020,24(25):3974-3980.
[43] 高承. 3D打印PLGA/HA生物活性支架直接修复大鼠股骨缺损及生物相容性的实验研究[D].青岛:青岛大学,2019.
[44] CUI HX, GUO J, HAN Z, et al. Biocompatibility of differently proportioned HA/PLGA/BMP-2 composite biomaterials in rabbits. Genet Mol Res. 2015;14(4):13511-13518.
[45] LI J, JAHR H, ZHENG W, et al. Visualizing Angiogenesis by Multiphoton Microscopy In Vivo in Genetically Modified 3D-PLGA/nHAp Scaffold for Calvarial Critical Bone Defect Repair. J Vis Exp. 2017;127(7):55381.
[46] CUI L, ZHANG J, ZOU J, et al. Electroactive composite scaffold with locally expressed osteoinductive factor for synergistic bone repair upon electrical stimulation. Biomaterials. 2020;230:119617.
[47] LI M, LIU J, CUI X, et al. Osteogenesis effects of magnetic nanoparticles modified-porous scaffolds for the reconstruction of bone defect after bone tumor resection. Regen Biomater. 2019;6(6):373-381.
[48] 于婷,刘娅,王宇,等.改性纳米羟基磷灰石/PLGA复合材料的制备及生物活性[J].高等学校化学学报,2009,30(7):1439-1444.
[49] JOSE MV, THOMAS V, JOHNSON KT, et al. Aligned PLGA/HA nanofibrous nanocomposite scaffolds for bone tissue engineering. Acta Biomater. 2009;5(1):305-315.
[50] ZHENG S, GUAN Y, YU H, et al. Poly-L-lysine-coated PLGA/poly(amino acid)-modified hydroxyapatite porous scaffolds as efficient tissue engineering scaffolds for cell adhesion, proliferation, and differentiation. New J Chem. 2019;43(25):9989-10002.
[51] PARK JW, HWANG JU, BACK JH, et al. High strength PLGA/Hydroxyapatite composites with tunable surface structure using PLGA direct grafting method for orthopedic implants. Compos B Eng. 2019;178:107449.
[52] SHI X, WU H, YAN H, et al. Electroactive Nanocomposite Porous Scaffolds of PAPn/op-HA/PLGA Enhance Osteogenesis in Vivo. ACS Appl Bio Mater. 2019;2(4):1464-1476.
[53] DOS SANTOS TMBK, MERLINI C, ARAGONES Á, et al. Manufacturing and characterization of plates for fracture fixation of bone with biocomposites of poly (lactic acid-co-glycolic acid) (PLGA) with calcium phosphates bioceramics. Mater Sci Eng C Mater Biol Appl. 2019;103: 109728.
[54] 史耕田,马志勇,钱正,等.基于高温挤出打印的PLGA/β-磷酸三钙人工骨支架制备及其性能研究[J].北京生物医学工程,2020, 39(3):264-270+284.
[55] 王宁宁.3D打印PDA/PLGA/β-磷酸三钙复合组织工程支架的制备及相关研究[D].长春:吉林大学,2019.
[56] BARBER FA, SPENCINER DB, BHATTACHARYYA S, et al. Biocomposite Implants Composed of Poly(Lactide-co-Glycolide)/β-Tricalcium Phosphate: Systematic Review of Imaging, Complication, and Performance Outcomes. Arthroscopy. 2017;33(3): 683-689.
[57] NEPOLA JC, PETERSEN EB, DEVRIES-WATSON N, et al. Electrospun PLGA and β-TCP(Rebossis-85) in a Lapine Posterolateral Fusion Model. Iowa Orthop J. 2019;39(2):9-19.
[58] ZHANG R, LI S, YIN Y, et al. Open-Wedge HTO with Absorbable β-TCP/PLGA Spacer Implantation and Proximal Fibular Osteotomy for Medial Compartmental Knee Osteoarthritis: New Technique Presentation. J Invest Surg. 2019;2019(8):1-11.
[59] PROBST FA, FLIEFEL R, BURIAN E, et al. Bone regeneration of minipig mandibular defect by adipose derived mesenchymal stem cells seeded tri-calcium phosphate- poly(D,L-lactide-co-glycolide) scaffolds. Sci Rep. 2020;10(1):2062.
[60] GO EJ, KANG EY, LEE SK, et al. An osteoconductive PLGA scaffold with bioactive β-TCP and anti-inflammatory Mg(OH)2 to improve in vivo bone regeneration. Biomater Sci. 2020;8(3):937-948.
[61] LAI Y, LI Y, CAO H, et al. Osteogenic magnesium incorporated into PLGA/TCP porous scaffold by 3D printing for repairing challenging bone defect. Biomaterials. 2019;197:207-219.
[62] MAGRI AMP, FERNANDES KR, KIDO HW, et al. Bioglass/PLGA associated to photobiomodulation: effects on the healing process in an experimental model of calvarial bone defect. J Mater Sci Mater Med. 2019;30(9):105.
[63] YANG L, LIU S, FANG W, et al. Poly(lactic-co-glycolic acid)-bioactive glass composites as nanoporous scaffolds for bone tissue engineering: In vitro and in vivo studies. Exp Ther Med. 2019;18(6):4874-4880.
[64] BOSE S, FIELDING G, TARAFDER S, et al. Understanding of dopant-induced osteogenesis and angiogenesis in calcium phosphate ceramics. Trends Biotechnol. 2013;31(10):594-605.
[65] ZOU F, JIANG J, LV F, et al. Preparation of antibacterial and osteoconductive 3D-printed PLGA/Cu(I)@ZIF-8 nanocomposite scaffolds for infected bone repair. J Nanobiotechnology. 2020;18(1): 39.
[66] YANG CY, HUANG LY, SHEN TL, et al. Cell adhesion, morphology and biochemistry on nano-topographic oxidized silicon surfaces. Eur Cell Mater. 2010;20:415-430.
[67] WOJAK-CWIK I M, HINTZE V, SCHNABELRAUCH M, et al. Poly(L-lactide-co-glycolide) scaffolds coated with collagen and glycosaminoglycans: impact on proliferation and osteogenic differentiation of human mesenchymal stem cells. J Biomed Mater Res A. 2013;101(11):3109-3122.
[68] ZHU J, QI Z, ZHENG C, et al. Enhanced Cell Proliferation and Osteogenesis Differentiation through a Combined Treatment of Poly-L-Lysine-Coated PLGA/Graphene Oxide Hybrid Fiber Matrices and Electrical Stimulation. J Nanomater. 2020;2020:5892506.
[69] JIANG Y, XU Y. A mussel-inspired osteogenesis microenvironment with bioactive peptides for the dual-functionalization of biomedical substrates. New J Chem. 2020;44(33):14256-14265.
[70] RENTSCH B, BERNHARDT R, SCHARNWEBER D, et al. Embroidered and surface coated polycaprolactone-co-lactide scaffolds. Biomatter. 2012;2(3):158-165.
[71] WOJAK-ĆWIK IM, RUMIAN Ł, KROK-BORKOWICZ M, et al. Synergistic effect of bimodal pore distribution and artificial extracellular matrices in polymeric scaffolds on osteogenic differentiation of human mesenchymal stem cells. Mater Sci Eng C Mater Biol Appl. 2019;97: 12-22.
[72] 王闯建,刘宏建,张春霖,等.喷墨全包芯骨支架材料的制备及生物安全性研究[J].中华实验外科杂志,2019,36(5):915-918.
[73] SHIMER AL, ONER FC, VACCARO AR. Spinal reconstruction and bone morphogenetic proteins: open questions. Injury. 2009;40(Suppl 3): S32-38.
|